Cargando…
Podocyte Autophagy: A Potential Therapeutic Target to Prevent the Progression of Diabetic Nephropathy
Diabetic nephropathy (DN), a leading cause of end-stage renal disease (ESRD), becomes a worldwide problem. Ultrastructural changes of the glomerular filtration barrier, especially the pathological changes of podocytes, lead to proteinuria in patients with diabetes. Podocytes are major components of...
Autores principales: | Liu, Na, Xu, Liuqing, Shi, Yingfeng, Zhuang, Shougang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420432/ https://www.ncbi.nlm.nih.gov/pubmed/28512641 http://dx.doi.org/10.1155/2017/3560238 |
Ejemplares similares
-
Pharmacologic targeting ERK1/2 attenuates the development and progression of hyperuricemic nephropathy in rats
por: Liu, Na, et al.
Publicado: (2017) -
Delayed treatment with an autophagy inhibitor 3-MA alleviates the progression of hyperuricemic nephropathy
por: Shi, Yingfeng, et al.
Publicado: (2020) -
Pharmacological inhibition of autophagy by 3-MA attenuates hyperuricemic nephropathy
por: Bao, Jinfang, et al.
Publicado: (2018) -
Apelin involved in progression of diabetic nephropathy by inhibiting autophagy in podocytes
por: Liu, Yu, et al.
Publicado: (2017) -
Connexin 43-autophagy loop in the podocyte injury of diabetic nephropathy
por: Ji, Jialing, et al.
Publicado: (2019)